| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.05B | +6.0% |
| Cost of Revenue | $520.8M | +1.0% |
| Gross Profit | $530.8M | +11.3% |
| R&D Expense | $25.8M | +5.0% |
| SG&A Expense | $260.9M | +11.7% |
| Operating Income | $208.8M | +19.2% |
| Interest Expense | $67.1M | +1047.0% |
| Pre-tax Income | $144.2M | +42.6% |
| Income Tax | $25.5M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $196.6M | +10.4% |
| Short-term Investments | $0 | -100.0% |
| Accounts Receivable | $278.6M | +2.8% |
| Inventory | $216.5M | +0.6% |
| Current Assets | $767.0M | +5.8% |
| Total Assets | $2.99B | +1.5% |
| Current Liabilities | $313.0M | +30.6% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $212.1M | +14.9% |
| Capital Expenditures | $24.3M | -21.6% |
| Investing Cash Flow | -$54.1M | +2.3% |
| Financing Cash Flow | -$136.8M | -1697.0% |
| Free Cash Flow | $187.8M | +22.3% |
| +25.1% |
| Net Income | $118.7M | +47.1% |
| EPS (Basic) | $0.55 | +44.7% |
| EPS (Diluted) | $0.54 | +45.9% |
| Long-term Debt |
| $971.5M |
| -12.3% |
| Total Liabilities | $1.57B | -4.2% |
| Stockholders' Equity | $1.42B | +8.6% |